作者
Catherine G Tran, Scott K Sherman, Mohammed O Suraju, Apoorve Nayyar, Henning Gerke, Rami G El Abiad, Chandrikha Chandrasekharan, Po Hien Ear, Thomas M O’Dorisio, Joseph S Dillon, Andrew M Bellizzi, James R Howe
发表日期
2022/1
期刊
Annals of surgical oncology
卷号
29
页码范围
75-84
出版商
Springer International Publishing
简介
Background
Management of duodenal neuroendocrine tumors (DNETs) is not standardized, with smaller lesions (< 1–2 cm) generally treated by endoscopic mucosal resection (EMR) and larger DNETs by surgical resection (SR). This study reviewed how patients were selected for treatment and compared outcomes.
Patients and Methods
Patients with DNETs undergoing resection were identified through institutional databases, and clinicopathologic data recorded. χ2 and Wilcoxon tests compared variables. Survival was determined by Kaplan–Meier, and Cox regression tested association with survival.
Results
Among 104 patients, 64 underwent EMR and 40 had SR. Patients selected for SR had larger tumor size, younger age, and higher T, N, and M stage. There was no difference in progression-free (PFS) or overall …
引用总数
学术搜索中的文章